A detailed history of Veriti Management LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Veriti Management LLC holds 5,641 shares of TECH stock, worth $387,649. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,641
Previous 5,654 0.23%
Holding current value
$387,649
Previous $405,000 11.11%
% of portfolio
0.02%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$70.96 - $82.35 $922 - $1,070
-13 Reduced 0.23%
5,641 $450,000
Q2 2024

Aug 02, 2024

BUY
$62.12 - $84.15 $49,261 - $66,730
793 Added 16.31%
5,654 $405,000
Q1 2024

Apr 19, 2024

BUY
$65.98 - $77.09 $6,136 - $7,169
93 Added 1.95%
4,861 $342,000
Q4 2023

Feb 05, 2024

BUY
$52.83 - $78.22 $20,498 - $30,349
388 Added 8.86%
4,768 $367,000
Q3 2023

Oct 27, 2023

SELL
$67.52 - $89.42 $48,006 - $63,577
-711 Reduced 13.97%
4,380 $298,000
Q2 2023

Jul 13, 2023

BUY
$73.76 - $85.98 $31,790 - $37,057
431 Added 9.25%
5,091 $415,000
Q1 2023

Apr 26, 2023

BUY
$71.62 - $86.62 $45,550 - $55,090
636 Added 15.81%
4,660 $345,000
Q4 2022

Jan 20, 2023

BUY
$80.67 - $352.29 $239,912 - $1.05 Million
2,974 Added 283.24%
4,024 $0
Q3 2022

Oct 26, 2022

BUY
$282.54 - $391.85 $27,406 - $38,009
97 Added 10.18%
1,050 $298,000
Q2 2022

Jul 18, 2022

BUY
$322.67 - $449.65 $14,520 - $20,234
45 Added 4.96%
953 $330,000
Q1 2022

Apr 11, 2022

SELL
$353.85 - $487.79 $353 - $487
-1 Reduced 0.11%
908 $393,000
Q4 2021

Jan 19, 2022

SELL
$456.15 - $525.06 $15,052 - $17,326
-33 Reduced 3.5%
909 $470,000
Q3 2021

Oct 08, 2021

BUY
$444.87 - $538.88 $23,578 - $28,560
53 Added 5.96%
942 $456,000
Q2 2021

Jul 13, 2021

BUY
$387.35 - $450.26 $344,354 - $400,281
889 New
889 $400,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.7B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Veriti Management LLC Portfolio

Follow Veriti Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veriti Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veriti Management LLC with notifications on news.